This page serves as the chronological archive of all MarketSpeaker content, organizing published material by date rather than topic or format. It aggregates news, briefs, guides, and other editorial outputs into a time-based structure, allowing readers to track coverage across specific periods. Designed for researchers, analysts, and returning readers, the archive provides a clear historical view of market narratives and reporting cycles. Unlike category or tag pages, it emphasizes temporal navigation over thematic grouping.
Chinese robotics company Unitree has priced its Shanghai IPO at a $9 billion valuation, becoming the first mainland-listed humanoid robot manufacturer as China accelerates investment in AI-powered robotics.
Nikita Bier has stepped down as Head of Product at X as SpaceX employees become eligible to sell their shares on the public market for the first time.
A Saudi-led investor consortium has completed its $55 billion acquisition of Electronic Arts, taking the gaming giant private in one of the largest deals in video game industry history.
Bending Spoons has agreed to acquire Airtable for $1.285 billion in cash, buying the enterprise software company at a steep discount to its $11 billion valuation during the 2021 technology boom.
SpaceX will release its first quarterly earnings report as a public company, with investors closely watching Starlink growth, AI spending, profitability, and future guidance.
Palantir shares surged 16% after the company reported stronger-than-expected second-quarter results, driven by explosive U.S. commercial demand for AI software and rising interest in sovereign AI tools.
Alibaba shares climbed 5% after the company unveiled Qwen3.8-Max, its most advanced AI model to date, positioning it against leading models from OpenAI, Anthropic, and Google.
OpenAI, Anthropic, and other leading AI companies face increased regulatory scrutiny as the European Union begins enforcing key provisions of its landmark AI Act.
Amazon’s market capitalization surpassed $3 trillion for the first time after a strong quarterly earnings report showed accelerating cloud growth driven by rising demand for AI infrastructure.
AstraZeneca and Bristol Myers Squibb have held discussions about a potential merger valued at more than $400 billion, a deal that would create one of the world’s largest pharmaceutical companies.